APA (7th ed.) Citation

Lonati, C., Berezhnoy, G., Lawler, N., Masuda, R., Kulkarni, A., Sala, S., . . . Trautwein, C. (2024). Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD+ pathway and SIRT1 activation. Clinical chemistry and laboratory medicine, 62(4), 770-788. https://doi.org/10.1515/cclm-2023-1017

Chicago Style (17th ed.) Citation

Lonati, Caterina, et al. "Urinary Phenotyping of SARS-CoV-2 Infection Connects Clinical Diagnostics with Metabolomics and Uncovers Impaired NAD+ Pathway and SIRT1 Activation." Clinical Chemistry and Laboratory Medicine 62, no. 4 (2024): 770-788. https://doi.org/10.1515/cclm-2023-1017.

MLA (9th ed.) Citation

Lonati, Caterina, et al. "Urinary Phenotyping of SARS-CoV-2 Infection Connects Clinical Diagnostics with Metabolomics and Uncovers Impaired NAD+ Pathway and SIRT1 Activation." Clinical Chemistry and Laboratory Medicine, vol. 62, no. 4, 2024, pp. 770-788, https://doi.org/10.1515/cclm-2023-1017.